1. Home
  2. BHC vs GAB Comparison

BHC vs GAB Comparison

Compare BHC & GAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHC
  • GAB
  • Stock Information
  • Founded
  • BHC N/A
  • GAB 1986
  • Country
  • BHC Canada
  • GAB United States
  • Employees
  • BHC N/A
  • GAB N/A
  • Industry
  • BHC Biotechnology: Pharmaceutical Preparations
  • GAB Investment Managers
  • Sector
  • BHC Health Care
  • GAB Finance
  • Exchange
  • BHC Nasdaq
  • GAB Nasdaq
  • Market Cap
  • BHC 1.7B
  • GAB 1.8B
  • IPO Year
  • BHC N/A
  • GAB N/A
  • Fundamental
  • Price
  • BHC $6.18
  • GAB $5.69
  • Analyst Decision
  • BHC Hold
  • GAB
  • Analyst Count
  • BHC 5
  • GAB 0
  • Target Price
  • BHC $7.20
  • GAB N/A
  • AVG Volume (30 Days)
  • BHC 2.5M
  • GAB 667.8K
  • Earning Date
  • BHC 07-31-2025
  • GAB 01-01-0001
  • Dividend Yield
  • BHC N/A
  • GAB 10.91%
  • EPS Growth
  • BHC N/A
  • GAB N/A
  • EPS
  • BHC N/A
  • GAB N/A
  • Revenue
  • BHC $9,731,000,000.00
  • GAB N/A
  • Revenue This Year
  • BHC $3.71
  • GAB N/A
  • Revenue Next Year
  • BHC $5.03
  • GAB N/A
  • P/E Ratio
  • BHC N/A
  • GAB N/A
  • Revenue Growth
  • BHC 8.53
  • GAB N/A
  • 52 Week Low
  • BHC $3.96
  • GAB $4.56
  • 52 Week High
  • BHC $9.85
  • GAB $5.88
  • Technical
  • Relative Strength Index (RSI)
  • BHC 73.53
  • GAB 47.90
  • Support Level
  • BHC $4.41
  • GAB $5.55
  • Resistance Level
  • BHC $6.31
  • GAB $5.79
  • Average True Range (ATR)
  • BHC 0.27
  • GAB 0.06
  • MACD
  • BHC 0.17
  • GAB -0.03
  • Stochastic Oscillator
  • BHC 92.89
  • GAB 32.86

About BHC Bausch Health Companies Inc.

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

About GAB Gabelli Equity Trust Inc. (The)

Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.

Share on Social Networks: